Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171782725> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2171782725 endingPage "B12" @default.
- W2171782725 startingPage "B12" @default.
- W2171782725 abstract "Lung cancer affecting populations in different geographical areas varies with respect to incidence, smoking history, histology and response to treatment with monoclonal antibodies inhibiting EGFR. Assessment of EGFR status in lung cancer varies with respect to methodology, type of antibody etc, resulting in wide variation in reported incidence of positivity. In addition EGFR receptor is a polyclonal antigen (eg: EGFR1, EGFR2) and standardization of antigen methodology of assessment and interpretation of the test results is not yet uniformly accepted worldwide. Response to treatment with monoclonal antibodies to EGFR in lung cancer patients vis a vis receptor status is varied in different geographical areas. Study in Erlotinib has shown response in selected sample of patients in western population whereas there are no well established clinical trials in Asian population establishing relevance of receptor status with respect to clinical response to EFGR antibodies. It is well known fact from different clinical trials that Asian especially Southeast Asian populations with lung cancer respond differently in comparison to European population (cacuasions). But receptor status and response to treatment not known. Hence it is opinioned that Asian and especially Southeast Asians population9s treatment with monoclonal antibodies should be given a clinical trial irrespective of receptor status or unknown receptor status. However clinical trials with respect to response v/s receptor status should be conducted. Till then these populations should not be denied treatment with monoclonal antibodies in lung cancer (NSCLC)." @default.
- W2171782725 created "2016-06-24" @default.
- W2171782725 creator A5078908491 @default.
- W2171782725 date "2012-02-01" @default.
- W2171782725 modified "2023-09-26" @default.
- W2171782725 title "Abstract B12: Predictibility of response to anti-EGFR treatment with respect to assessment of receptor status in different geographical population with lung cancer (NSCLC)" @default.
- W2171782725 doi "https://doi.org/10.1158/1078-0432.12aacriaslc-b12" @default.
- W2171782725 hasPublicationYear "2012" @default.
- W2171782725 type Work @default.
- W2171782725 sameAs 2171782725 @default.
- W2171782725 citedByCount "0" @default.
- W2171782725 crossrefType "journal-article" @default.
- W2171782725 hasAuthorship W2171782725A5078908491 @default.
- W2171782725 hasConcept C121608353 @default.
- W2171782725 hasConcept C126322002 @default.
- W2171782725 hasConcept C143998085 @default.
- W2171782725 hasConcept C159654299 @default.
- W2171782725 hasConcept C203014093 @default.
- W2171782725 hasConcept C2776256026 @default.
- W2171782725 hasConcept C2778087573 @default.
- W2171782725 hasConcept C2779438470 @default.
- W2171782725 hasConcept C2908647359 @default.
- W2171782725 hasConcept C535046627 @default.
- W2171782725 hasConcept C542903549 @default.
- W2171782725 hasConcept C71924100 @default.
- W2171782725 hasConcept C99454951 @default.
- W2171782725 hasConceptScore W2171782725C121608353 @default.
- W2171782725 hasConceptScore W2171782725C126322002 @default.
- W2171782725 hasConceptScore W2171782725C143998085 @default.
- W2171782725 hasConceptScore W2171782725C159654299 @default.
- W2171782725 hasConceptScore W2171782725C203014093 @default.
- W2171782725 hasConceptScore W2171782725C2776256026 @default.
- W2171782725 hasConceptScore W2171782725C2778087573 @default.
- W2171782725 hasConceptScore W2171782725C2779438470 @default.
- W2171782725 hasConceptScore W2171782725C2908647359 @default.
- W2171782725 hasConceptScore W2171782725C535046627 @default.
- W2171782725 hasConceptScore W2171782725C542903549 @default.
- W2171782725 hasConceptScore W2171782725C71924100 @default.
- W2171782725 hasConceptScore W2171782725C99454951 @default.
- W2171782725 hasIssue "3 Supplement" @default.
- W2171782725 hasLocation W21717827251 @default.
- W2171782725 hasOpenAccess W2171782725 @default.
- W2171782725 hasPrimaryLocation W21717827251 @default.
- W2171782725 hasRelatedWork W1980223409 @default.
- W2171782725 hasRelatedWork W2038944279 @default.
- W2171782725 hasRelatedWork W2042581859 @default.
- W2171782725 hasRelatedWork W2522361623 @default.
- W2171782725 hasRelatedWork W2590894457 @default.
- W2171782725 hasRelatedWork W2614031963 @default.
- W2171782725 hasRelatedWork W2752467782 @default.
- W2171782725 hasRelatedWork W2771500922 @default.
- W2171782725 hasRelatedWork W2780750179 @default.
- W2171782725 hasRelatedWork W2806172899 @default.
- W2171782725 hasRelatedWork W2888217055 @default.
- W2171782725 hasRelatedWork W2906751293 @default.
- W2171782725 hasRelatedWork W2947109922 @default.
- W2171782725 hasRelatedWork W2967521016 @default.
- W2171782725 hasRelatedWork W3005289617 @default.
- W2171782725 hasRelatedWork W3042556268 @default.
- W2171782725 hasRelatedWork W3049121642 @default.
- W2171782725 hasRelatedWork W3095431747 @default.
- W2171782725 hasRelatedWork W2112901415 @default.
- W2171782725 hasRelatedWork W2401959160 @default.
- W2171782725 hasVolume "18" @default.
- W2171782725 isParatext "false" @default.
- W2171782725 isRetracted "false" @default.
- W2171782725 magId "2171782725" @default.
- W2171782725 workType "article" @default.